Dr Sarwan Bishnoi 520 South Road, Kurralta Park, South Australia 5037

Welcome to the webpage for Dr Sarwan Bishnoi, a renowned institution located in Kurralta Park, Australia. Dr Sarwan Bishnoi is a highly skilled doctor specializing in adult and pediatric medical oncology and malignant hematology. After completing his postgraduate degree in internal medicine from the University of Rajasthan, he underwent specialist training at KIMIO in Bangalore and CMC Vellore.

Dr Bishnoi's expertise lies in the treatment of colorectal, lung, breast, and head and neck cancers. With his extensive knowledge and experience, he was inducted as a fellow into The Royal Australian College of Physicians in 2011, following advanced oncology training at Flinders Medical Centre and The Queen Elizabeth Hospital.

Having worked as a medical oncologist at The Queen Elizabeth Hospital and Lyell McEwin Hospital, Dr Bishnoi has gained vast experience in managing a wide variety of solid tumors in different clinical settings. He also has a keen interest in clinical research and research ethics, with over 30 publications in various peer-reviewed journals, including the Journal of Clinical Oncology, Annals of Oncology, Journal of Geriatric Oncology, Oral Oncology, and Asia-Pacific Journal of Clinical Oncology.

Dr Bishnoi actively participates in the ethics committee, where he reviews research protocols from international cooperative research groups, ensuring scientific validity, merit, integrity, and ethical conduct. He is an active member of numerous professional bodies and societies, staying up-to-date with the latest advancements in oncology.

Currently, Dr Bishnoi is involved in several research studies, including a Phase I, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activities of an Anti-ROR1 Antibody Drug Conjugate in Patients with Advanced Solid Tumors and Lymphomas. Additionally, he is studying the effectiveness of BGB-15025 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants with Advanced Solid Tumors.

If you are seeking comprehensive and cutting-edge cancer treatment, look no further than Dr Sarwan Bishnoi. With his expertise, dedication to research, and commitment to ethical medical practice, you can trust that you are in capable hands. Contact us today to schedule an appointment and start your journey towards better health.